Fixed Treatment Duration Mosunetuzumab in Patients With Relapsed or Refractory Follicular Lymphoma: Perspectives From US Advanced Practice Providers.

Guerrero MR, Averill B, Clermont L, Pak S, Kiernan J, Wu M, Lai D, To I, Farighi R, Piela M

DOI: 10.6004/jadpro.2026.17.7.19
Published: 2026 Jul 1
Container: Journal of the advanced practitioner in oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.6004/jadpro.2026.17.7.19,
  title = {Fixed Treatment Duration Mosunetuzumab in Patients With Relapsed or Refractory Follicular Lymphoma: Perspectives From US Advanced Practice Providers.},
  author = {Guerrero MR and Averill B and Clermont L and Pak S and Kiernan J and Wu M and Lai D and To I and Farighi R and Piela M},
  year = {2026},
  journal = {Journal of the advanced practitioner in oncology},
  doi = {10.6004/jadpro.2026.17.7.19},
  url = {https://doi.org/10.6004/jadpro.2026.17.7.19}
}

RIS

TY  - JOUR
TI  - Fixed Treatment Duration Mosunetuzumab in Patients With Relapsed or Refractory Follicular Lymphoma: Perspectives From US Advanced Practice Providers.
AU  - Guerrero MR
AU  - Averill B
AU  - Clermont L
AU  - Pak S
AU  - Kiernan J
AU  - Wu M
AU  - Lai D
AU  - To I
AU  - Farighi R
AU  - Piela M
PY  - 2026
JO  - Journal of the advanced practitioner in oncology
DO  - 10.6004/jadpro.2026.17.7.19
UR  - https://doi.org/10.6004/jadpro.2026.17.7.19
ER  -

APA

MR, G., B, A., L, C., S, P., J, K., M, W., D, L., I, T., R, F., & M, P. (2026). Fixed Treatment Duration Mosunetuzumab in Patients With Relapsed or Refractory Follicular Lymphoma: Perspectives From US Advanced Practice Providers.. Journal of the advanced practitioner in oncology. https://doi.org/10.6004/jadpro.2026.17.7.19

Source records

pubmed · retrieved 2026-09-26T09:36:17.054Z